BioSpace News Archive

Increasing use of MRI systems for the early detection of diseases has surged the growth of the medical devices industry. With continuous technology advancements, rising preference for non-invasive diagnosis, and increasing incidence of neurological disorders, the global MRI systems market will witness 2X growth by market value over the forecast period of 2019 to 2029.

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its first quarter 2020 financial results on Monday, May 11, 2020 at 5:00 p.m. Eastern Time.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the commencement of a proposed public offering of $75.0 million of shares of its common stock.

New York think tank, Altru Institute has organized the Altru Global Virus Project to aggregate and curate the best information globally and to foster collaboration among scientists, physicians and entrepreneurs developing cures and treatments worldwide

According to a new market report published by Persistence Market Research, titled “Australia and New Zealand Market Study on Surgical and Respirator Masks: Australia to Witness Highest Growth by 2021”, the surgical and respiratory mask market in Australia and New Zealand is expected to reach US$137.8 Mn by the end of 2015 and is anticipated to expand at a CAGR of 3.3% from 2015 to 2021, to reach US$167.7 Mn by 2021.

Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced the appointment of Carrie Brownstein, M.D., to the role of Chief Medical Officer

Revolutionary device developed by Vent Multiplexor LLC in collaboration with Yale New Haven Hospital is the first device ever produced to provide temporary dual patient rescue mechanical ventilation with individualized patient care until an additional ventilator is available to resume single mechanical ventilation.

Applied Biology, Inc. (“Applied Biology”) announced today it has licensed to Applied Botanics, LLC. (Louisville, KY) intellectual property rights to a novel cannabinoid based therapy under development for COVID-19 and other respiratory illnesses.

ASLAN intends to resume screening as soon as government restrictions are lifted and is taking steps to open sites in Australia to accelerate recruitment

AstraZeneca and Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration has approved the kinase inhibitor KOSELUGO for the treatment of pediatric patients two years of age and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.